Jump to content

  • Set Your Location
  • Sign in or Enroll
Set Your LocationSet Your Location
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Research
  • Investigators
  • Kristie Bobolis
Content

Investigator Kristie A. Bobolis, M.D.

Kristie A. Bobolis, M.D.

 
Kristie Bobolis, MD is a research investigator with the Sutter Roseville Medical Center


Sutter Health Research Enterprise
8 Medical Plaza
Suite 300
Roseville, CA, 95661
(916) 782-5106  
bobolik@sutterhealth.org

Primary Research Interests

  • Brain Cancer
  • Breast Cancer
  • Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Gastrointestinal Cancer
  • Genetics
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Skin Cancer/Melanoma
  • Skin Cancer
  • Solid Tumors

Related Clinical Trials

Adjuvant (Alliance A011801 Compass HER2 Residual Disease)

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Investigator: Kristie A. Bobolis M.D.

Status: Active, Recruiting

Adjuvant (NRG BN007) Temp Hold

Use of Immunotherapy Ipilimumab and Nivolumab Plus RT Compared to Usual Trmt (Temozolomide and RT) for Newly Dx MGMT Unmethylated Glioblastoma

Investigator: Kristie A. Bobolis M.D.

Status: Active, Not Recruiting

Adjuvant Breast (EndoPredict Extended Endocrine Trial EXET Myriad)

To evaluate the impact of using EndoPredict clinically to inform treatment decisions for extended endocrine therapy and the subsequent impact on patient outcome

Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D.

Status: Active, Recruiting

City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives

The purpose of this study is to find out how genetics, biologics and behavior might contribute to

Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.

Status: Active, Recruiting

Metastatic (AstraZeneca D533AC00001 MONETTE)

AstraZeneca D533AC00001 MONETTE: A Randomised, Open-Label, Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib plus Durvalumab in Patients with Unresect

Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Dron Gauchan MD, Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.

Status: Active, Recruiting

Neoadjuvant (ECOG-ACRIN EA1181 Compass HER2 pCR)

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Investigator: Kristie A. Bobolis M.D.

Status: Active, Recruiting

The Pathfinder 2 Study (Grail)

Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population

Investigators: Deepti Behl MD, Kristie A. Bobolis M.D., Alex J. Garica-Young MD, Charles McDonnell MD, FACR, Sivakumar Reddy M.D., Nitin Rohatgi MD

Status: Active, Recruiting

Research Studies

Adjuvant (Guardant Health 02-MX-003 ORACLE)

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE)

Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.

Dana Farber 13-09-259 DCIS Registry

Molecular Characterization of Breast Cancer with Duct Forming Features

Investigator: Kristie A. Bobolis M.D.

Genomic Health Oncotype DX AR-V7

Genomic Health 09-060

Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D., David S Yee M.D., MPH

The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

  • Contact Us
  • Find Doctors
  • Find Locations
  • Request Medical Records
  • Make a Gift
Sign in to My Health Online

Billing and Insurance

  • Pay a Bill
  • Accepted Health Plans
  • Estimate Costs
  • Medicare Advantage

About Sutter

  • About Our Network
  • Community Benefit
  • Annual Report
  • News

Our Team

  • For Employees
  • For Medical Professionals
  • For Vendors
  • For Volunteers

Careers

  • Jobs at Sutter
  • Physician Jobs
  • Graduate Medical Education

Copyright © 2023 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

  • ADA Accessibility
  • Privacy
  • Do Not Sell My Personal Information
  • LinkedIn Opens new window
  • YouTube Opens new window
  • Facebook Opens new window
  • Twitter Opens new window
  • Instagram Opens new window
  • Glassdoor Opens new window

Cookie Policy

We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

Privacy Policy Cookie Preferences